The differences in rates of tumor development might result from the transplantability of each type of knockdown cell, and correspond to the variable survival rate of each type of knockdown cell at the initial stages of xenotransplantation, i.e., the poor tumorigenicity of RAB39A-knockdown cell was possibly related to the reduced cancer stemness in the cell. The gene discussed is RAB39A; the disease is cancer.